{"title":"\u30c6\u30ec\u30e1\u30c7\u30a3\u30b7\u30f3\u3000\u9060\u9694\u533b\u7642\u3000\u4e2d\u7d76\u85ac\u306b\u95a2\u3059\u308b\u8ad6\u6587","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fokumi.hatenablog.com%2Fentry%2F2025%2F03%2F31%2F164313\" title=\"\u30c6\u30ec\u30e1\u30c7\u30a3\u30b7\u30f3\u3000\u9060\u9694\u533b\u7642\u3000\u4e2d\u7d76\u85ac\u306b\u95a2\u3059\u308b\u8ad6\u6587 - \u30ea\u30d7\u30ed\u306a\u65e5\u8a18\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","height":"190","provider_url":"https://hatena.blog","version":"1.0","provider_name":"Hatena Blog","type":"rich","author_name":"okumi","categories":[],"author_url":"https://blog.hatena.ne.jp/okumi/","published":"2025-03-31 16:43:13","description":"\u5fd8\u5099\u9332 Mifeprex REMS Study Group. (2017). Sixteen years of overregulation: Time to unburden Mifeprex. The New England Journal of Medicine, 376(8), 790\u2013794. https://doi.org/10.1056/NEJMsb1612526 Abstract This Sounding Board article argues against the need for the currently required Risk Evaluation and M\u2026","blog_title":"\u30ea\u30d7\u30ed\u306a\u65e5\u8a18","url":"https://okumi.hatenablog.com/entry/2025/03/31/164313","width":"100%","blog_url":"https://okumi.hatenablog.com/","image_url":null}